Matches in SemOpenAlex for { <https://semopenalex.org/work/W3111318562> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W3111318562 abstract "Summary Objective The kainic acid (KA)-induced status epilepticus (SE) model in rats is an etiologically-relevant animal model of epileptogenesis. Just as in patients, who develop temporal lobe epilepsy (TLE) following SE, this rat model of KA-induced SE very closely recapitulates many of the clinical and pathological characteristics of human TLE that arise following SE or another neurological insult. Spontaneous recurrent seizures (SRS) in TLE can present after a latent period following a neurological insult (TBI, SE event, viral infection, etc.). Moreover, this rat model of TLE is ideally suited for preclinical studies to evaluate the long-term process of epileptogenesis and screen putative disease-modifying/antiepileptogenic agents. This report details the pharmacological characterization and methodological refinement of a moderate-throughput drug screening program using the post KA-induced SE model of epileptogenesis in male Sprague Dawley rats to identify potential agents that may prevent or modify the onset or severity of SRS. Specifically, we sought to demonstrate whether our protocol could prevent the development of SRS, or lead to a reduced frequency/severity of SRS. Methods Rats were administered everolimus (2-3 mg/kg, P.O. commencing at 1, 2, or 24-hrs after SE onset) or phenobarbital (60 mg/kg, beginning 1 hr after SE onset). The rats in all studies (n=12/treatment dose/study) were then followed intermittently by video-EEG monitoring; i.e., 2-weeks on/2-weeks off, 2-weeks on epochs to determine latency to onset of SRS, and disease burden following SRS onset. Results While there were no adverse side effects observed in any of our studies, no treatment conferred a significant disease modifying effect, nor did any agent prevent the presentation of SRS by 6 weeks post-SE onset. Conclusions While neither phenobarbital nor everolimus administered at several time points post-SE onset prevented the development of SRS, we herein demonstrate a moderate-throughput screen for potential antiepileptogenic agents in an etiologically-relevant rodent model of TLE. Key Points Disease-modifying therapies are needed to prevent or attenuate the burden of epilepsy in at-risk individuals. We report a moderate-throughput screening protocol to identify disease-modifying agents in a rat post-kainic acid status epilepticus model. Everolimus was administered at multiple time points post-status epilepticus with no effect on spontaneous seizures up to 6 weeks later. Repeated administration of phenobarbital also did not prevent the development of spontaneous recurrent seizures up to 6 weeks post SE. While we did not identify any effect of either agent, our approach provides a moderate-throughput screen for antiepileptogenesis." @default.
- W3111318562 created "2020-12-21" @default.
- W3111318562 creator A5002802588 @default.
- W3111318562 creator A5005402221 @default.
- W3111318562 creator A5013469993 @default.
- W3111318562 creator A5015735448 @default.
- W3111318562 creator A5058797510 @default.
- W3111318562 creator A5071806289 @default.
- W3111318562 creator A5088706930 @default.
- W3111318562 date "2020-12-15" @default.
- W3111318562 modified "2023-10-15" @default.
- W3111318562 title "Development of an Antiepileptogenesis Drug Screening Platform: Effects of Everolimus and Phenobarbital" @default.
- W3111318562 cites W1875451588 @default.
- W3111318562 cites W1991147561 @default.
- W3111318562 cites W2003829544 @default.
- W3111318562 cites W2007774397 @default.
- W3111318562 cites W2025256786 @default.
- W3111318562 cites W2027044444 @default.
- W3111318562 cites W2029569324 @default.
- W3111318562 cites W2035744498 @default.
- W3111318562 cites W2036747930 @default.
- W3111318562 cites W2038026687 @default.
- W3111318562 cites W2038888907 @default.
- W3111318562 cites W2039232100 @default.
- W3111318562 cites W2056134297 @default.
- W3111318562 cites W2057230367 @default.
- W3111318562 cites W2060969086 @default.
- W3111318562 cites W2066210618 @default.
- W3111318562 cites W2088237695 @default.
- W3111318562 cites W2091406481 @default.
- W3111318562 cites W2148683493 @default.
- W3111318562 cites W2162129563 @default.
- W3111318562 cites W2277113332 @default.
- W3111318562 cites W2316055407 @default.
- W3111318562 cites W2575416236 @default.
- W3111318562 cites W2588870577 @default.
- W3111318562 cites W2595043587 @default.
- W3111318562 cites W2610530916 @default.
- W3111318562 cites W2765795785 @default.
- W3111318562 cites W2787926732 @default.
- W3111318562 cites W2963246619 @default.
- W3111318562 cites W2999248741 @default.
- W3111318562 cites W3027752749 @default.
- W3111318562 cites W3081880165 @default.
- W3111318562 doi "https://doi.org/10.1101/2020.12.14.422712" @default.
- W3111318562 hasPublicationYear "2020" @default.
- W3111318562 type Work @default.
- W3111318562 sameAs 3111318562 @default.
- W3111318562 citedByCount "0" @default.
- W3111318562 crossrefType "posted-content" @default.
- W3111318562 hasAuthorship W3111318562A5002802588 @default.
- W3111318562 hasAuthorship W3111318562A5005402221 @default.
- W3111318562 hasAuthorship W3111318562A5013469993 @default.
- W3111318562 hasAuthorship W3111318562A5015735448 @default.
- W3111318562 hasAuthorship W3111318562A5058797510 @default.
- W3111318562 hasAuthorship W3111318562A5071806289 @default.
- W3111318562 hasAuthorship W3111318562A5088706930 @default.
- W3111318562 hasBestOaLocation W31113185621 @default.
- W3111318562 hasConcept C118552586 @default.
- W3111318562 hasConcept C2777341932 @default.
- W3111318562 hasConcept C2778186239 @default.
- W3111318562 hasConcept C2778793413 @default.
- W3111318562 hasConcept C57236427 @default.
- W3111318562 hasConcept C71924100 @default.
- W3111318562 hasConcept C98274493 @default.
- W3111318562 hasConceptScore W3111318562C118552586 @default.
- W3111318562 hasConceptScore W3111318562C2777341932 @default.
- W3111318562 hasConceptScore W3111318562C2778186239 @default.
- W3111318562 hasConceptScore W3111318562C2778793413 @default.
- W3111318562 hasConceptScore W3111318562C57236427 @default.
- W3111318562 hasConceptScore W3111318562C71924100 @default.
- W3111318562 hasConceptScore W3111318562C98274493 @default.
- W3111318562 hasLocation W31113185621 @default.
- W3111318562 hasOpenAccess W3111318562 @default.
- W3111318562 hasPrimaryLocation W31113185621 @default.
- W3111318562 hasRelatedWork W149227 @default.
- W3111318562 hasRelatedWork W16458591 @default.
- W3111318562 hasRelatedWork W17939609 @default.
- W3111318562 hasRelatedWork W19296689 @default.
- W3111318562 hasRelatedWork W20746225 @default.
- W3111318562 hasRelatedWork W2595097 @default.
- W3111318562 hasRelatedWork W2731895 @default.
- W3111318562 hasRelatedWork W6174028 @default.
- W3111318562 hasRelatedWork W9580581 @default.
- W3111318562 hasRelatedWork W14787492 @default.
- W3111318562 isParatext "false" @default.
- W3111318562 isRetracted "false" @default.
- W3111318562 magId "3111318562" @default.
- W3111318562 workType "article" @default.